These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 31745647)
1. Selecting the optimal risk threshold of diabetes risk scores to identify high-risk individuals for diabetes prevention: a cost-effectiveness analysis. Mühlenbruch K; Zhuo X; Bardenheier B; Shao H; Laxy M; Icks A; Zhang P; Gregg EW; Schulze MB Acta Diabetol; 2020 Apr; 57(4):447-454. PubMed ID: 31745647 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review. Zhou X; Siegel KR; Ng BP; Jawanda S; Proia KK; Zhang X; Albright AL; Zhang P Diabetes Care; 2020 Jul; 43(7):1593-1616. PubMed ID: 33534726 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of alternative thresholds of the fasting plasma glucose test to identify the target population for type 2 diabetes prevention in adults aged ≥45 years. Zhuo X; Zhang P; Kahn HS; Gregg EW Diabetes Care; 2013 Dec; 36(12):3992-8. PubMed ID: 24135386 [TBL] [Abstract][Full Text] [Related]
4. Alternative HbA1c cutoffs to identify high-risk adults for diabetes prevention: a cost-effectiveness perspective. Zhuo X; Zhang P; Selvin E; Hoerger TJ; Ackermann RT; Li R; Bullard KM; Gregg EW Am J Prev Med; 2012 Apr; 42(4):374-81. PubMed ID: 22424250 [TBL] [Abstract][Full Text] [Related]
5. The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease. Yarnoff BO; Hoerger TJ; Simpson SK; Leib A; Burrows NR; Shrestha SS; Pavkov ME; BMC Nephrol; 2017 Mar; 18(1):85. PubMed ID: 28288579 [TBL] [Abstract][Full Text] [Related]
6. The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design. Sun X; Guo L; Shang H; Ren M; Wang Y; Huo D; Lei X; Wang H; Zhai J Trials; 2015 Nov; 16():496. PubMed ID: 26530718 [TBL] [Abstract][Full Text] [Related]
7. Cost and clinical implications of diabetes prevention in an Australian setting: a long-term modeling analysis. Palmer AJ; Tucker DM Prim Care Diabetes; 2012 Jul; 6(2):109-21. PubMed ID: 22153888 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of a Stepwise Approach vs Standard Care for Diabetes Prevention in India. Islek D; Weber MB; Ranjit Mohan A; Mohan V; Staimez LR; Harish R; Narayan KMV; Laxy M; Ali MK JAMA Netw Open; 2020 Jul; 3(7):e207539. PubMed ID: 32725244 [TBL] [Abstract][Full Text] [Related]
9. Preventing type 2 diabetes: systematic review of studies of cost-effectiveness of lifestyle programmes and metformin, with and without screening, for pre-diabetes. Roberts S; Barry E; Craig D; Airoldi M; Bevan G; Greenhalgh T BMJ Open; 2017 Nov; 7(11):e017184. PubMed ID: 29146638 [TBL] [Abstract][Full Text] [Related]
10. Assessing the cost-effectiveness of drug and lifestyle intervention following opportunistic screening for pre-diabetes in primary care. Bertram MY; Lim SS; Barendregt JJ; Vos T Diabetologia; 2010 May; 53(5):875-81. PubMed ID: 20135088 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease. Pandya A; Sy S; Cho S; Weinstein MC; Gaziano TA JAMA; 2015 Jul; 314(2):142-50. PubMed ID: 26172894 [TBL] [Abstract][Full Text] [Related]
12. The cost-effectiveness of interventions targeting lifestyle change for the prevention of diabetes in a Swedish primary care and community based prevention program. Neumann A; Lindholm L; Norberg M; Schoffer O; Klug SJ; Norström F Eur J Health Econ; 2017 Sep; 18(7):905-919. PubMed ID: 27913943 [TBL] [Abstract][Full Text] [Related]
13. Achievable cost saving and cost-effective thresholds for diabetes prevention lifestyle interventions in people aged 65 years and older: a single-payer perspective. Anderson JM J Acad Nutr Diet; 2012 Nov; 112(11):1747-54. PubMed ID: 23102174 [TBL] [Abstract][Full Text] [Related]
14. Effects of lifestyle changes on adults with prediabetes: A systematic review and meta-analysis. Glechner A; Keuchel L; Affengruber L; Titscher V; Sommer I; Matyas N; Wagner G; Kien C; Klerings I; Gartlehner G Prim Care Diabetes; 2018 Oct; 12(5):393-408. PubMed ID: 30076075 [TBL] [Abstract][Full Text] [Related]
15. Two-stage, school and community-based population screening successfully identifies individuals and families at high-risk for type 2 diabetes: the Feel4Diabetes-study. Manios Y; Mavrogianni C; Lambrinou CP; Cardon G; Lindström J; Iotova V; Tankova T; Civeira F; Kivelä J; Jancsó Z; Shadid S; Tsochev K; Mateo-Gallego R; Radó S; Dafoulas G; Makrilakis K; Androutsos O; BMC Endocr Disord; 2020 Mar; 20(Suppl 1):12. PubMed ID: 32164646 [TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness of a Short Message Service Intervention to Prevent Type 2 Diabetes from Impaired Glucose Tolerance. Wong CK; Jiao FF; Siu SC; Fung CS; Fong DY; Wong KW; Yu EY; Lo YY; Lam CL J Diabetes Res; 2016; 2016():1219581. PubMed ID: 26798647 [TBL] [Abstract][Full Text] [Related]
17. A coordinated national model for diabetes prevention: linking health systems to an evidence-based community program. Vojta D; Koehler TB; Longjohn M; Lever JA; Caputo NF Am J Prev Med; 2013 Apr; 44(4 Suppl 4):S301-6. PubMed ID: 23498291 [TBL] [Abstract][Full Text] [Related]
18. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations]. Flórez H Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072 [TBL] [Abstract][Full Text] [Related]